Home/Filings/4/0001384101-24-000036
4//SEC Filing

Febbo Phillip G. 4

Accession 0001384101-24-000036

CIK 0001384101other

Filed

Mar 7, 7:00 PM ET

Accepted

Mar 8, 4:36 PM ET

Size

4.9 KB

Accession

0001384101-24-000036

Insider Transaction Report

Form 4
Period: 2024-03-06
Febbo Phillip G.
Chief Scientific & Med Officer
Transactions
  • Award

    Common Stock

    2024-03-06+39,90493,086 total
Footnotes (1)
  • [F1]Restricted stock units awarded on March 6, 2024 vest 25% on March 2, 2025 and 1/16 per quarter thereafter subject to continuing employment of the Reporting Person on each vesting date.

Issuer

VERACYTE, INC.

CIK 0001384101

Entity typeother

Related Parties

1
  • filerCIK 0001649245

Filing Metadata

Form type
4
Filed
Mar 7, 7:00 PM ET
Accepted
Mar 8, 4:36 PM ET
Size
4.9 KB